ACUTE MYELOID LEUKEMIA IN REMISSION
Clinical trials for ACUTE MYELOID LEUKEMIA IN REMISSION explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIA IN REMISSION trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA IN REMISSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to keep blood cancers at bay after transplant
Disease control OngoingThis study is testing whether taking the drug ruxolitinib after a stem cell transplant can help prevent cancer from returning in older patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). The trial involves 64 participants aged 60-80 who have achieved rem…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug combo aims to keep deadly blood cancer at bay
Disease control OngoingThis study is testing whether a two-drug combination (azacitidine and venetoclax) can help keep acute myeloid leukemia (AML) from returning in patients who have achieved remission. The trial will enroll 50 adults with AML who are in remission but are not immediate candidates for …
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New radiation technique tested to improve stem cell transplants for tough blood cancers
Disease control TerminatedThis early-stage study aims to find the safest and most effective dose of a targeted radiation treatment, given with chemotherapy, to prepare patients for a donor stem cell transplant. It is for people with high-risk forms of acute leukemia or myelodysplastic syndrome who are not…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New transplant method aims to cure blood diseases with fewer side effects
Disease control OngoingThis study is testing a modified bone marrow transplant procedure for adults and children with serious blood cancers and disorders. The goal is to treat the underlying disease while reducing the risk of a dangerous complication called graft-versus-host disease. Researchers use a …
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
Vaccinating donors to arm transplant patients against dangerous virus
Prevention OngoingThis study is testing a new approach to prevent a common and dangerous viral infection called CMV in people receiving a stem cell transplant for blood cancer. Researchers are giving a vaccine to the healthy stem cell donors before the transplant. The goal is to see if the donor's…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Prevention
Last updated Mar 25, 2026 14:08 UTC
-
Scientists hunt for early warning signs of Leukemia's return
Knowledge-focused OngoingThis study aims to learn if tracking tiny amounts of leftover leukemia cells in the blood can help doctors predict and understand relapse in patients with acute myeloid leukemia (AML) who have received a stem cell transplant. Researchers will follow 303 adult patients in remissio…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Knowledge-focused
Last updated Apr 02, 2026 02:26 UTC